Director, Global Market Access Strategy – Genetic Disease & Reproducti…
Illumina- Full Time
- Expert & Leadership (9+ years)
The Sr. Director - Global Diagnostics Pathways & Policy will be responsible for developing strategic plans to address patient access and affordability barriers to diagnostic testing. This role requires up-to-date knowledge of the global diagnostic coverage and reimbursement ecosystem to support key markets in initiative creation and prioritization, ultimately supporting innovation and launch readiness for biomarker-directed medicines.
Develops and delivers prescription medicines globally
Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.